Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors
- 23 September 2009
- journal article
- research article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 25 (11), 2703-2709
- https://doi.org/10.1185/03007990903307755
Abstract
(2009). Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors. Current Medical Research and Opinion: Vol. 25, No. 11, pp. 2703-2709. doi: 10.1185/03007990903307755Keywords
This publication has 24 references indexed in Scilit:
- Cost‐Effectiveness of Diabetes Case Management for Low‐Income PopulationsHealth Services Research, 2007
- Long-Term Drug Treatment of GERDDisease Management and Health Outcomes, 2004
- Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for HeartburnValue in Health, 2002
- Population based epidemiological survey of gastroesophageal reflux disease in hospitalized U.S. childrenGastroenterology, 2001
- Lansoprazole in the treatment of gastrooesophageal reflux disease in childhoodDigestive and Liver Disease, 2000
- Economic analysis of step‐wise treatment of gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1999
- Gastro‐oesophageal reflux in infantsActa Paediatrica, 1999
- Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: Endoscopic healing and twenty-four-hour intragastric acidityThe Journal of Pediatrics, 1996
- Gastroesophageal Reflux in the Older Child: Presentation, Response to Treatment and Long-Term Follow-UpClinical Pediatrics, 1991
- Gastroesophageal Reflux in ChildrenClinical Pediatrics, 1987